FDA Inspection 1002583 - Biotest Pharmaceuticals Corp. - January 25, 2017
FDA Inspection 1002583 for Biotest Pharmaceuticals Corp. on January 25, 2017. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1002583 for Biotest Pharmaceuticals Corp. on January 25, 2017. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
January 25, 2017
Product Type
Biologics
ID: 64efdbff-4fc2-4fc0-a7cf-4c71f795ad15
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox